|
1
|
Egan KM, Seddon JM, Glynn RJ, Gragoudas ES
and Albert DM: Epidemiologic aspects of uveal melanoma. Surv
Ophthalmol. 32:239–251. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kam R, Hayungs J, Bomfeld N, Sauerwein W,
Höffken K and Seeber S: Prognosis and treatment of disseminated
uveal melanoma. Cancer. 72:2219–2223. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qu S, Yang X, Li X, Wang J, Gao Y, Shang
R, Sun W, Dou K and Li H: Circular RNA: A new star of noncoding
RNAs. Cancer Lett. 365:141–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen LL: The biogenesis and emerging roles
of circular RNAs. Nat Rev Mol Cell Biol. 17:205–211. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li J, Yang J, Zhou P, Le Y, Zhou C, Wang
S, Xu D, Lin HK and Gong Z: Circular RNAs in cancer: Novel insights
into origins, properties, functions and implications. Am J Cancer
Res. 5:472–480. 2015.PubMed/NCBI
|
|
6
|
Wang F, Nazarali AJ and Ji S: Circular
RNAs as potential biomarkers for cancer diagnosis and therapy. Am J
Cancer Res. 6:1167–1176. 2016.PubMed/NCBI
|
|
7
|
Shao Y and Chen Y: Roles of circular RNAs
in neurologic disease. Front Mol Neurosci. 9:252016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu D and Xu AD: Mini review: Circular RNAs
as potential clinical biomarkers for disorders in the central
nervous system. Front Genet. 7:532016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Z, Huang C, Bao C, Chen L, Lin M, Wang
X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs
regulate transcription in the nucleus. Nat Struct Mol Biol.
22:256–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ashwal-Fluss R, Meyer M, Pamudurti NR,
Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N and
Kadener S: circRNA biogenesis competes with pre-mRNA splicing. Mol
Cell. 56:55–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hansen TB, Kjems J and Damgaard CK:
Circular RNA and miR-7 in cancer. Cancer Res. 73:5609–5612. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li F, Zhang L, Li W, Deng J, Zheng J, An
M, Lu J and Zhou Y: Circular RNA ITCH has inhibitory effect on ESCC
by suppressing the Wnt/β-catenin pathway. Oncotarget. 6:6001–6013.
2015.PubMed/NCBI
|
|
15
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suzuki H, Zuo Y, Wang J, Zhang MQ,
Malhotra A and Mayeda A: Characterization of RNase R-digested
cellular RNA source that consists of lariat and circular RNAs from
pre-mRNA splicing. Nucleic Acids Res. 34:e632006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suzuki H and Tsukahara T: A view of
pre-mRNA splicing from RNase R resistant RNAs. Int J Mol Sci.
15:9331–9342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xuan L, Qu L, Zhou H, Wang P, Yu H, Wu T,
Wang X, Li Q, Tian L, Liu M and Sun Y: Circular RNA: A novel
biomarker for progressive laryngeal cancer. Am J Transl Res.
8:932–939. 2016.PubMed/NCBI
|
|
19
|
Qin M, Liu G, Huo X, Tao X, Sun X, Ge Z,
Yang J, Fan J, Liu L and Qin W: Hsa_circ_0001649: A circular RNA
and potential novel biomarker for hepatocellular carcinoma. Cancer
Biomark. 16:161–169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Zhang Y, Huang L, Zhang J, Pan F,
Li B, Yan Y, Jia B, Liu H, Li S and Zheng W: Decreased expression
of hsa_circ_001988 in colorectal cancer and its clinical
significances. Int J Clin Exp Pathol. 8:16020–16025.
2015.PubMed/NCBI
|
|
21
|
Hansen TB, Wiklund ED, Bramsen JB,
Villadsen SB, Statham AL, Clark SJ and Kjems J: miRNA-dependent
gene silencing involving Ago2-mediated cleavage of a circular
antisense RNA. EMBO J. 30:4414–4422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Valdmanis PN and Kay MA: The expanding
repertoire of circular RNAs. Mol Ther. 21:1112–1114. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kefas B, Godlewski J, Comeau L, Li Y,
Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S and
Purow B: microRNA-7 inhibits the epidermal growth factor receptor
and the Akt pathway and is down-regulated in glioblastoma. Cancer
Res. 68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reddy SD, Ohshiro K, Rayala SK and Kumar
R: MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase
1 and regulates its functions. Cancer Res. 68:8195–8200. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Webster RJ, Giles KM, Price KJ, Zhang PM,
Mattick JS and Leedman PJ: Regulation of epidermal growth factor
receptor signaling in human cancer cells by microRNA-7. J Biol
Chem. 284:5731–5741. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiong S, Zheng Y, Jiang P, Liu R, Liu X
and Chu Y: MicroRNA-7 inhibits the growth of human non-small cell
lung cancer A549 cells through targeting BCL-2. Int J Biol Sci.
7:805–814. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rybak-Wolf A, Stottmeister C, Glazar P,
Jens M, Pino N, Giusti S, Hanan M, Behm M, Bartok O, Ashwal-Fluss
R, et al: Circular RNAs in the mammalian brain are highly abundant,
conserved, and dynamically expressed. Mol Cell. 58:870–885. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peng L, Yuan XQ and Li GC: The emerging
landscape of circular RNA ciRS-7 in cancer. Oncol Rep.
33:2669–2674. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xie H, Ren X, Xin S, Lan X, Lu G, Lin Y,
Yang S, Zeng Z, Liao W, Ding YQ and Liang L: Emerging roles of
circRNA_001569 targeting miR-145 in the proliferation and invasion
of colorectal cancer. Oncotarget. 7:26680–26691. 2016.PubMed/NCBI
|
|
30
|
Zhong Z, Lv M and Chen J: Screening
differential circular RNA expression profiles reveals the
regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in
bladder carcinoma. Sci Rep. 6:309192016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou C, Liu G, Wang L, Lu Y, Yuan L, Zheng
L, Chen F, Peng F and Li X: MiR-339-5p regulates the growth, colony
formation and metastasis of colorectal cancer cells by targeting
PRL-1. PLoS One. 8:e631422013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu ZS, Wu Q, Wang CQ, Wang XN, Wang Y,
Zhao JJ, Mao SS, Zhang GH, Zhang N and Xu XC: MiR-339-5p inhibits
breast cancer cell migration and invasion in vitro and may be a
potential biomarker for breast cancer prognosis. BMC Cancer.
10:5422010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang C, Liu J, Wang X, Wu R, Lin M,
Laddha SV, Yang Q, Chan CS and Feng Z: MicroRNA-339-5p inhibits
colorectal tumorigenesis through regulation of the MDM2/p53
signaling. Oncotarget. 5:9106–9117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu Z, Wu Y, Tian Y, Sun X, Liu J, Ren H,
Liang C, Song L, Hu H, Wang L and Jiao B: Differential effects of
miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and
invasion of glioma cells. Oncol Lett. 6:1447–1452. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Berthois Y, Delfino C, Metellus P, Fina F,
Nanni-Metellus I, Al Aswy H, Pirisi V, Ouafik L and Boudouresque F:
Differential expression of miR-200a-3p and miR21 in grade II–III
and grade IV gliomas: Evidence that miR-200a-3p is regulated by
O6-methylguanine methyltransferase and promotes temozolomide
responsiveness. Cancer Biol Ther. 15:938–950. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou Y, Chen Q, Qin R, Zhang K and Li H:
MicroRNA-449a reduces cell survival and enhances cisplatin-induced
cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells.
Tumour Biol. 35:12369–12378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yao Y, Ma J, Xue Y, Wang P, Li Z, Li Z, Hu
Y, Shang X and Liu Y: MiR-449a exerts tumor-suppressive functions
in human glioblastoma by targeting Myc-associated zinc-finger
protein. Mol Oncol. 9:640–656. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shang Y, Zhang Z, Liu Z, Feng B, Ren G, Li
K, Zhou L, Sun Y, Li M, Zhou J, et al: miR-508-5p regulates
multidrug resistance of gastric cancer by targeting ABCB1 and
ZNRD1. Oncogene. 33:3267–3276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang L, Yang L, Liu X, Chen W, Chang L,
Chen L, Loera S, Chu P, Huang WC, Liu YR and Yen Y: MicroRNA-657
promotes tumorigenesis in hepatocellular carcinoma by targeting
transducin-like enhancer protein 1 through nuclear factor kappa B
pathways. Hepatology. 57:1919–1930. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shan SW, Fang L, Shatseva T, Rutnam ZJ,
Yang X, Du W, Lu WY, Xuan JW, Deng Z and Yang BB: Mature miR-17-5p
and passenger miR-17-3p induce hepatocellular carcinoma by
targeting PTEN, GalNT7 and vimentin in different signal pathways. J
Cell Sci. 126:1517–1530. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chaudhry MA, Sachdeva H and Omaruddin RA:
Radiation-induced micro-RNA modulation in glioblastoma cells
differing in DNA-repair pathways. DNA Cell Biol. 29:553–561. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhai H, Song B, Xu X, Zhu W and Ju J:
Inhibition of autophagy and tumor growth in colon cancer by
miR-502. Oncogene. 32:1570–1579. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tang J, Tao ZH, Wen D, Wan JL, Liu DL,
Zhang S, Cui JF, Sun HC, Wang L, Zhou J, et al: MiR-612 suppresses
the stemness of liver cancer via Wnt/β-catenin signaling. Biochem
Biophys Res Commun. 447:210–215. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li R, Zhang L, Jia L, Duan Y, Li Y, Wang
J, Bao L and Sha N: MicroRNA-143 targets Syndecan-1 to repress cell
growth in melanoma. PLoS One. 9:e948552014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jin L, Hu WL, Jiang CC, Wang JX, Han CC,
Chu P, Zhang LJ, Thorne RF, Wilmott J, Scolyer RA, et al:
MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic
regulator in human melanoma. Proc Natl Acad Sci USA. 108:pp.
15840–15845. 2011; View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li JR, Wang JQ, Gong Q, Fang RH and Guo
YL: MicroRNA-328 inhibits proliferation of human melanoma cells by
targeting TGFβ2. Asian Pac J Cancer Prev. 16:1575–1579. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu R, Xie H, Luo C, Chen Z, Zhou X, Xia
K, Chen X, Zhou M, Cao P, Cao K and Zhou J: Identification of FLOT2
as a novel target for microRNA-34a in melanoma. J Cancer Res Clin
Oncol. 141:993–1006. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhou J, Xu D, Xie H, Tang J, Liu R, Li J,
Wang S, Chen X, Su J, Zhou X, et al: miR-33a functions as a tumor
suppressor in melanoma by targeting HIF-1α. Cancer Biol Ther.
16:846–855. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Elson-Schwab I, Lorentzen A and Marshall
CJ: MicroRNA-200 family members differentially regulate
morphological plasticity and mode of melanoma cell invasion. PLoS
One. 5(pii): e131762010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Satzger I, Mattern A, Kuettler U,
Weinspach D, Voelker B, Kapp A and Gutzmer R: MicroRNA-15b
represents an independent prognostic parameter and is correlated
with tumor cell proliferation and apoptosis in malignant melanoma.
Int J Cancer. 126:2553–2562. 2010.PubMed/NCBI
|
|
51
|
Martin de Campo SE, Latchana N, Levine KM,
Grignol VP, Fairchild ET, Jaime-Ramirez AC, Dao TV, Karpa VI,
Carson M, Ganju A, et al: MiR-21 enhances melanoma invasiveness via
inhibition of tissue inhibitor of metalloproteinases 3 expression:
In vivo effects of MiR-21 inhibitor. PLoS One. 10:e01159192015.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhou J, Liu R, Wang Y, Tang J, Tang S,
Chen X, Xia K, Xiong W, Xu D, Wang S, et al: miR-199a-5p regulates
the expression of metastasis-associated genes in B16F10 melanoma
cells. Int J Clin Exp Pathol. 7:7182–7190. 2014.PubMed/NCBI
|
|
53
|
Schmitt MJ, Philippidou D, Reinsbach SE,
Margue C, Wienecke-Baldacchino A, Nashan D, Behrmann I and Kreis S:
Interferon-γ-induced activation of signal transducer and activator
of transcription 1 (STAT1) up-regulates the tumor suppressing
microRNA-29 family in melanoma cells. Cell Commun Signal.
10:412012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Bhattacharya A, Schmitz U, Wolkenhauer O,
Schönherr M, Raatz Y and Kunz M: Regulation of cell cycle
checkpoint kinase WEE1 by miR-195 in malignant melanoma. Oncogene.
32:3175–3183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sun L, Bian G, Meng Z, Dang G, Shi D and
Mi S: MiR-144 inhibits uveal melanoma cell proliferation and
invasion by regulating c-Met expression. PLoS One. 10:e01244282015.
View Article : Google Scholar : PubMed/NCBI
|
